OSR Health, Inc. 8-K

What Happened
On July 31, 2026, OSR Health, Inc. filed a Form 8‑K (Regulation FD disclosure) reporting that The Nasdaq Stock Market LLC verbally informed the company that OSR’s Shareholder Loyalty Contingent Value Rights (CVR) program will not result in any mechanical adjustment to the price of OSR common stock upon (a) distribution of the CVRs or (b) delivery of additional shares to enrolled holders. The company furnished a related press release as Exhibit 99.1.

Key Details

• Filing date: July 31, 2026 (Form 8‑K, Item 7.01 disclosure).
• Subject: Nasdaq’s verbal position that the Loyalty CVR distribution and related share deliveries will not trigger a mechanical price adjustment.
• Limitations: Nasdaq’s statement relates only to exchange price‑adjustment treatment; it is not an endorsement of the CVR program or an investment in OSR.
• Regulatory status: Securities‑law requirements and the company’s ongoing regulatory process for the CVR distribution remain outstanding and are unaffected by Nasdaq’s price‑adjustment position.

Why It Matters
This disclosure clarifies how Nasdaq expects to treat the proposed CVR distribution for price‑adjustment mechanics, which is an important technical detail for shareholders and market reporting. However, it does not resolve legal or regulatory approvals required for the CVR program, nor does it endorse the program or investment in OSR. Investors should watch for further company filings and regulatory updates for final determinations and any material changes.